Endothelial dysfunction in diabetes
Open accessThe DOI matches its Crossref record; 114 of the 115 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Endothelial dysfunction plays a key role in the pathogenesis of diabetic vascular disease. The endothelium controls the tone of the underlying vascular smooth muscle through the production of vasodilator mediators. The endothelium‐derived relaxing factors (EDRF) comprise nitric oxide (NO), prostacyclin, and a still elusive endothelium‐derived hyperpolarizing factor (EDHF). Impaired endothelium‐dependent vasodilation has been demonstrated in various vascular beds of different animal models of diabetes and in humans with type 1 and 2 diabetes. Several mechanisms of endothelial dysfunction have been reported, including impaired signal transduction or substrate availibility, impaired release of EDRF, increased destruction of EDRF, enhanced release of endothelium‐derived constricting factors and decreased sensitivity of the vascular smooth muscle to EDRF. The principal mediators of hyperglycaemia‐induced endothelial dysfunction may be activation of protein kinase C, increased activity of the polyol pathway, non‐enzymatic glycation and oxidative stress. Correction of these pathways, as well as administration of ACE inhibitors and folate, has been shown to improve endothelium‐dependent vasodilation in diabetes. Since the mechanisms of endothelial dysfunction appear to differ according to the diabetic model and the vascular bed under study, it is important to select clinically relevant models for future research of endothelial dysfunction. British Journal of Pharmacology (2000) 130 , 963–974; doi: 10.1038/sj.bjp.0703393
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both hyperglycemia and hyperinsulinemia alter the endothelium,27 disrupting the normal atheroprotective nitric oxide regulatory environment and encouraging a generalized proinflammatory, vasoconstrictive state predisposing to atherothrombosis.27–29”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [28]
Experimental — accuracy not yet measuredIn the citing paper
“Impaired endothelium-dependent vasodilation has been demonstrated in various vascular beds of animal models of diabetes and humans with type 1 and type 2 diabetes (80).”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [80]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441 · cited 1×
“Although AGE formation occurs during the normal ageing process, it is markedly accelerated during diabetes, as a consequence of an increase in substrate, e.g. glucose, and in the prevailing oxidant stress in this disease (Baynes & Thorpe, 1999).”
BackgroundEndothelium‐derived relaxing and contracting factors
Furchgott, R. F., & Vanhoutte, P. M. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.9.2545495 · Cited by 1,993
Self-citationOxidative Stress and Diabetic Vascular Complications
Giugliano, D., Ceriello, A., & Paolisso, G. (1996) · Diabetes Care · doi:10.2337/diacare.19.3.257 · Cited by 1,930
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
Protein kinase C activation and the development of diabetic complications.
Koya, D., & King, G. L. (1998) · Diabetes · doi:10.2337/diabetes.47.6.859 · Cited by 1,330
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,306
Wolff, S. P., & Dean, R. T. (1987) · Biochemical Journal · doi:10.1042/bj2450243 · Cited by 1,271
Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor
Rubanyi, G. M., & Vanhoutte, P. M. (1986) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1986.250.5.h822 · Cited by 1,188
Self-citationBucala, R., Tracey, K. J., & Cerami, A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115014 · Cited by 1,165
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Johnstone, M. T., Creager, S. J., Scales, K. M., Cusco, J. A., Lee, B. K., & Creager, M. A. (1993) · Circulation · doi:10.1161/01.cir.88.6.2510 · Cited by 1,124
Research works printed but not linked: 6
- DE VRIESE A., 1999, Impaired endothelium‐derived hyperpolarizing factormediated renal vasodilatory response in diabetes: restoration with folate, J. Am. Soc. Nephrol., 10, 394A
- FRIEDMAN E.A., 1999, Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications, Diabetes Care, 22, B65
- FULTON D., 1996, Cytochrome P450 arachidonate metabolites: deficit in diabetes mellitus, FASEB J., 9, A113
- QUILLEY J., 1996, NO‐independent coronary vasodilation to bradykinin in diabetes, Hypertension, 28, P178
- 10.2337/diabetes.42.9.1246 · doi:10.2337/diabetes.42.9.1246
- 10.1042/cs19980382 · doi:10.1042/cs19980382
Cited by
Items 601–700 of 1,000
Microvascular basis of cognitive impairment in type 1 diabetes
Sharma, S., & Brown, C. E. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107929 · Cited by 24
Andlib, N., Sajad, M., & Thakur, S. C. (2024) · Acta Histochemica · doi:10.1016/j.acthis.2024.152173 · Cited by 24
Padmalayam, I. (2012) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/187152512802651060 · Cited by 24
“For a more detailed overview of the role of ROS in the atherosclerotic disease process, please see references [12, 27, 29-35].”
BackgroundZhao, Y., Sun, H., Wang, B., Zhang, M., Luo, X., Ren, Y., Zhou, J., Han, C., Wang, C., Li, L., et al. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.04.006 · Cited by 24
Endothelial dysfunction in children with type 1 diabetes mellitus
do Nascimento, A. M. M. D. A., Sequeira, I. J., Vasconcelos, D. F., Gandolfi, L., Pratesi, R., & Nóbrega, Y. K. D. M. (2017) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000271 · Cited by 24
“Macrovascular and microvascular complications are the main causes of morbidity and mortality in patients with diabetes mellitus, and their main trigger may be represented by dysregulation of the modulatory function of the vascular endothelium (15).”
BackgroundTownsend, D. K., Deysher, D. M., Wu, E. E., & Barstow, T. J. (2019) · Experimental Physiology · doi:10.1113/ep087216 · Cited by 24
Diabetic Retinopathy and Vascular Endothelial Growth Factor Gene Insertion/Deletion Polymorphism
Khan, S. Z., Ajmal, N., & Shaikh, R. (2019) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2019.08.005 · Cited by 24
Glycated hemoglobin and subsequent risk of microvascular and macrovascular complications
Samanta, S. (2020) · Indian Journal of Medical Sciences · doi:10.25259/ijms_16_2020 · Cited by 24
Nokhoijav, E., Guba, A., Kumar, A., Kunkli, B., Kalló, G., Káplár, M., Somodi, S., Garai, I., Csutak, A., Tóth, N., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094534 · Cited by 24
Oğuz, A., Uzunlulu, M., Yorulmaz, E., Yalçın, Y., Hekim, N., & Fıcı, F. (2007) · PubMed · Cited by 24
Protective effect of taurine on diabetic rat endothelial dysfunction
Ikubo, N., Saito, M., Tsounapi, P., Dimitriadis, F., Ohmasa, F., Inoue, S., Shimizu, S., Kinoshita, Y., & Satoh, K. (2011) · Biomedical Research · doi:10.2220/biomedres.32.187 · Cited by 24
Matsumoto, T., Noguchi, E., Ishida, K., Nakayama, N., Kobayashi, T., & Kamata, K. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.006 · Cited by 24
Experimental Models for Vascular Endothelial Dysfunction
Balakumar, P., Jindal, S., Shah, D. I., & Singh, M. (2007) · Trends in Medical Research · doi:10.3923/tmr.2007.12.20 · Cited by 24
Quan, Y., He, X., Luo, K.-F., Zhang, G., Liu, Y., Qin, X. Y., Hou, N., Chen, W., & Luo, J. (2012) · Current Therapeutic Research · doi:10.1016/j.curtheres.2012.09.002 · Cited by 24
“Macrovascular and microvascular diseases are currently the principal causes of morbidity and mortality in patients with T2DM; dysfunction of the vascular endothelial cell is considered an initiating factor, and it plays a critical role in the development of diabetic vascular complications.(4) However, the etiology of…”
Laakso, M. (2003) · European Heart Journal Supplements · doi:10.1016/s1520-765x(03)90035-6 · Cited by 24
Vasodilator effects of adenosine on retinal arterioles in streptozotocin-induced diabetic rats
Nakazawa, T., Mori, A., Saito, M., Sakamoto, K., Nakahara, T., & Ishii, K. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0233-z · Cited by 24
“In various vascular beds, diabetes impairs the endothelium-dependent vasodilation mediated by NO (Taylor et al. 1992; Oyama et al. 1986; De Vriese et al. 2000).”
BackgroundColeman, H. A., Tare, M., & Parkington, H. C. (2002) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.03701.x · Cited by 24
Taguchi, K., Kobayashi, T., Hayashi, Y., Matsumoto, T., & Kamata, K. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.11.026 · Cited by 24
Anderson, L. C., & Garrett, J. R. (2003) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2003.09.004 · Cited by 24
García, M., Morán, A., Calama, E., Martín, M. L., Barthelmebs, M., & Román, L. S. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706216 · Cited by 24
“…to vascular reactivity, alterations in peripheral nerve sensitivity or to endothelial dysfunction due to induced diabetes (Ralevic et al., 1995; De Vriese et al., 2000; Miranda et al., 2000; 2002), and they are in agreement with some data pointing to modifications in the 5-HT receptor population,…”
ResultThomas, E., Ficarra, S., Nakamura, M., Drid, P., Trivić, T., & Bianco, A. (2024) · Sports Medicine - Open · doi:10.1186/s40798-023-00661-w · Cited by 23
Sexual Dysfunction in Men and Women
Bhasin, S., & Basson, R. J. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00020-1 · Cited by 24
Mazrouei, S., Sharifpanah, F., Caldwell, R. W., Franz, M., Shatanawi, A., Muessig, J. M., Fritzenwanger, M., Schulze, P. C., & Jung, C. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.05.004 · Cited by 23
Heart Failure and Diabetes Mellitus: Dangerous Liaisons
Lee, H. (2022) · International Journal of Heart Failure · doi:10.36628/ijhf.2022.0022 · Cited by 23
Tagougui, S., Fontaine, P., Leclair, E., Aucouturier, J., Matran, R., Oussaidene, K., Descatoire, A., Prieur, F., Mucci, P., Vambergue, A., et al. (2015) · Diabetes Care · doi:10.2337/dc14-1792 · Cited by 23
“The impairment in cerebral vasoreactivity appears all the more marked in cases of high HbA1c levels (7), which is not surprising considering the deleterious effect of chronic hyperglycemia on endothelial function (8).”
BackgroundKamata, K., Kanie, N., Matsumoto, T., & Kobayashi, T. (2004) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000166241.49453.e9 · Cited by 23
“Thus, endothelial dysfunction is likely to play a key role in the pathogenesis of diabetic vasculopathy.(10) Oxygen-derived free radicals are involved in mediating the effects of vascular injury in various disease states, such as diabetes;(11) for example, superoxide dismutase (SOD) activity is reduced in aortas from…”
BackgroundNitric Oxide and Cardiovascular Risk Factors
Raddino, R., Caretta, G., Teli, M., Bonadei, I., Robba, D., Zanini, G., Madureri, A., Nodari, S., & Cas, L. D. (2007) · Heart International · doi:10.1177/1826186807003001-203 · Cited by 23
Matsumoto, T., Ishida, K., Taguchi, K., Kobayashi, T., & Kamata, K. (2009) · Peptides · doi:10.1016/j.peptides.2009.06.014 · Cited by 23
Jesmin, S., Zaedi, S., Maeda, S., Yamaguchi, I., Goto, K., & Miyauchi, T. (2006) · PubMed · Cited by 23
Matsumoto, T., Kobayashi, T., & Kamata, K. (2006) · Current Cardiology Reviews · doi:10.2174/157340306778019405 · Cited by 23
“This has been linked to elevated oxidative stress and is characterized by impaired NO-mediated endothelium-dependent relaxation, as noted for numerous individual vessels and vascular beds, including aorta, basilar and cerebral arteries, corpus cavernosum, and renal and mesenteric vascular beds [7, 9-17].”
InfluentialDistefano, G., Zanoli, L., Basile, A., Fatuzzo, P. M., & Granata, A. R. M. (2019) · The Journal of Vascular Access · doi:10.1177/1129729819838180 · Cited by 22
The Role of Inflammation as a Preponderant Risk Factor in Cardiovascular Diseases
García, R. D., Asensio, J. A., Perdicaro, D. J., & Peral, M. D. L. Á. (2022) · Current Vascular Pharmacology · doi:10.2174/1570161120666220201160038 · Cited by 22
Chan, G. H. H., Law, B. Y. K., Chu, J. M. T., Yue, K. K. M., Jiang, Z., Lau, C., Huang, Y., Chan, S., Yue, P. Y., & Wong, R. N. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/797310 · Cited by 22
Lee, C., Hsieh, M., Chang, S., Hung, K., Wang, C., Hsu, M., Juang, J., Hsieh, I.-C., Wen, M., & Liu, S. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s211898 · Cited by 22
Azemi, A. K., Mokhtar, S. S., Hou, L. J., Sharif, S. E. T., & Rasool, A. H. G. (2020) · Biotechnic & Histochemistry · doi:10.1080/10520295.2020.1823480 · Cited by 22
“Also, oxygen-derived free radicals may impair endotheliumdependent vasodilatation by inactivation of NO or by serving as an EDCF (De Vriese et al. 2000).”
BackgroundInteractions between diabetes and COVID-19: A narrative review
Sabri, S., Bourron, O., Phan, F., & Nguyen, L. S. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i10.1674 · Cited by 22
Krüppel-Like Factor 2 Suppression by High Glucose as a Possible Mechanism of Diabetic Vasculopathy
Lee, H., Youn, S., Oh, B., & Kim, H.-S. (2012) · Korean Circulation Journal · doi:10.4070/kcj.2012.42.4.239 · Cited by 22
Effect of sodium selenite treatment on platelet aggregation of streptozotocin-induced diabetic rats
Ersöz, G., Yakaryılmaz, A., & Turan, B. (2003) · Thrombosis Research · doi:10.1016/s0049-3848(03)00338-4 · Cited by 22
“oxidative mechanisms may also be involved in diabetesinduced platelet abnormalities [1,3,4].”
BackgroundEndothelial dysfunction in myometrial arteries of women with gestational diabetes
Chirayath, H. H., Wareing, M., Taggart, M. J., & Baker, P. N. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.03.022 · Cited by 22
Arterial stiffness and endothelial inflammation in prediabetes and newly diagnosed diabetes patients
Çakar, M., Balta, Ş., Şarlak, H., Akhan, M., Demırkol, S., Karaman, M., Ay, S. A., Kurt, Ö., Çaycı, T., İnal, S., et al. (2015) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000061 · Cited by 22
“The IFG and IGT groups were not age and BMI-matched to the control group, but T2DM group was the same as control group in terms of these parameters.”
BackgroundInfluentialHypertrophic scar regression is linked to the occurrence of endothelial dysfunction
Wang, X., Song, F., & Liu, Y.-K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176681 · Cited by 22
Bansal, S., & Chopra, K. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.07.017 · Cited by 22
Qin, L., Mroczkowska, S., Ekárt, A., Patel, S. R., Gibson, J. M., & Gherghel, D. (2013) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-013-2418-0 · Cited by 22
“Our observations, although in need of future validations, could represent evidence that early screening for CVD and therapeutic intervention to modify risk factors such as high cholesterol, oxidative stress and endothelial dysfunction might prevent future health burdens in patients suffering from AMD.”
BackgroundInfluentialLlorens, S., Miranda, F. J., Alabadí, J. A., Marrachelli, V. G., & Alborch, E. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.12.003 · Cited by 22
“Diabetes alters the responsiveness of different vascular beds to several vasoconstrictors and vasodilators, and it has been hypothesised that endothelial dysfunction could partially explain many of these altered responses (Haller, 1997; De Vriese et al., 2000).”
BackgroundMatsumoto, T., Ishida, K., Kobayashi, T., & Kamata, K. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09116fp · Cited by 22
Coronary microvascular function in patients with type 2 diabetes mellitus
Leung, M., & Leung, D. Y. (2016) · EuroIntervention · doi:10.4244/eijy15m03_09 · Cited by 22
Oniki, H., Fujii, K., Kansui, Y., Gotō, K., & Iida, M. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000200518.34980.cc · Cited by 22
Diabetes potentiates acetylcholine-induced relaxation in rabbit renal arteries
Alabadí, J. A., Miranda, F. J., Llorens, S., de Apodaca, R. F. R., Centeno, J. M., & Alborch, E. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00832-9 · Cited by 22
“Vriese et al., 2000 .”
Antihypertensive effect of ragaglitazar: A novel PPARα and γ dual activator
Mamnoor, P., Hegde, M. N., Datla, S. S. V., Damarla, R. K. B., RAJAGOPALAN, R., & Chakrabarti, R. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2006.03.020 · Cited by 22
Zhang, Y., Cao, Y., Zhang, X., Lin, J., Jiang, M., Zhang, X., Dai, X., Zhang, X., Liu, Y., Wen, G., et al. (2024) · Advanced Science · doi:10.1002/advs.202405543 · Cited by 21
Diabetes mellitus associated cardiovascular signalling alteration: A need for the revisit
Sharma, A. K., & Khanna, D. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.01.022 · Cited by 21
Li, J. C., Velagic, A., Qin, C. X., Li, M., Leo, C. H., Kemp‐Harper, B. K., Ritchie, R. H., & Woodman, O. L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.585740 · Cited by 21
Nikzamir, A., Esteghamati, A., Hamedian, A. A., & Mahmoudi, T. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-0812-4 · Cited by 21
“VEGF is a potent multifunctional cytokine which plays a key role in the pathogenesis of diabetic microvascular complications [32–36].”
BackgroundHigh glucose increases B1-kinin receptor expression and signaling in endothelial cells
Rodriguez, A. I., Pereira‐Flores, K., Hernández, R., Borić, M. P., & Velarde, V. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.127 · Cited by 21
Gupta, S., Sharma, S. B., Singh, U. R., & Bansal, S. K. (2011) · Cardiovascular Toxicology · doi:10.1007/s12012-011-9120-4 · Cited by 21
Mohamadin, A. M., Hammad, L. N., El‐Bab, M. F., & Gawad, H. S. A. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04622.x · Cited by 21
“It has been suggested that MDA can facilitate the auto-oxidation of glucose to dicarbonyl intermediates, an early step in the Maillard reaction.54 Anti-oxidant enzymes constitute the first line of defence against ROS.6 In normal physiological processes, CAT and GPx participate in the removal of H2O2 from cells, wherea…”
BackgroundRauchfuss, S., Geiger, J., Walter, U., Renné, T., & Gambaryan, S. P. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.02925.x · Cited by 21
Altered response of human umbilical artery to 5-HT in gestational diabetic pregnancy
Radenković, M., Radunović, N. V., Momčilov, P., & Grbović, L. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70095-7 · Cited by 20
“Our observed endothelium-independent contraction of vascular preparations in GDM is consistent with an already established relationship between pathological alterations in endothelial cells and diabetes [6].”
BackgroundResultNigella sativa seed decreases endothelial dysfunction in streptozotocin-induced diabetic rat aorta.
Abbasnezhad, A., Niazmand, S., Mahmoudabady, M., Soukhtanloo, M., Rezaee, S. A., & Mousavi, S. M. (2016) · PubMed Central · Cited by 20
Azgomi, R. N. D., Karimi, A., Zarshenas, M. M., & Jazani, A. M. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.102365 · Cited by 20
Elçioğlu, H. K., Kabasakal, L., Özkan, N., Çelikel, Ç., & Ayanoğlu‐Dülger, G. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.03.030 · Cited by 20
Salheen, S. M., Panchapakesan, U., Pollock, C. A., & Woodman, O. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143941 · Cited by 20
“Endothelial dysfunction is considered a critical factor in the initiation and development of vascular complications induced by diabetes [1, 2].”
BackgroundMethodInfluentialRuia, S., Saxena, S., Prasad, S., Sharma, S., Akduman, L., & Khanna, V. K. (2016) · International Journal of Retina and Vitreous · doi:10.1186/s40942-016-0033-z · Cited by 20
“Endothelial damage due to accumulation of AGEs, activation of PKC, increased expression of VEGF and intracellular adhesion molecule (ICAM-1), increase in ROS leads to breakdown of BRB resulting in diabetic macular edema [36–39].”
BackgroundTaguchi, K., Bessho, N., Kaneko, N., Okudaira, K., Matsumoto, T., & Kobayashi, T. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172776 · Cited by 20
Yan, Z., Cao, X., Wang, C., Liu, S., Li, Y., Gan, L., Yan, W., Guo, R., Zhao, D., Cao, J.-M., et al. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114745 · Cited by 20
Diabetes Mellitus And Cardiovascular Risk
Unachukwu, C., & Ofori, S. (2012) · The Internet Journal of Endocrinology · doi:10.5580/2b1d · Cited by 20
Ceroni, L., Ellis, A., Wiehler, W. B., Jiang, Y., Ding, H., & Triggle, C. R. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.01.018 · Cited by 20
Thomas, G. N., Jiang, C. Q., McGhee, S. M., Zhang, W. S., Lao, X. Q., Schooling, C. M., Adab, P., Lam, T. H., & Cheng, K. K. (2006) · Metabolism · doi:10.1016/j.metabol.2006.03.014 · Cited by 20
“These end products are responsible for a range of effects, including quenching nitric oxide, and contributing to oxidative stress and inflammatory processes [19,20].”
BackgroundKinoshita, Y., Saito, M., Satoh, I., Shomori, K., Suzuki, H., Yamada, M., Kono, T., & Satoh, K. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.07.043 · Cited by 20
Impaired microvascular insulin-dependent dilation in women with a history of gestational diabetes
Schwartz, K., Hernandez, P., Maurer, G. S., Wetzel, E. M., Sun, M., Jalal, D. I., & Stanhewicz, A. E. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00223.2024 · Cited by 19
Leiva, A., de Medina, C. D., Guzmn-Gutirrez, E., Pardo, F., & Sobrevi, L. (2013) · InTech eBooks · doi:10.5772/55297 · Cited by 19
Gender Differences in Endothelial Function in Aortas From Type 2 Diabetic Model Mice
Takenouchi, Y., Kobayashi, T., Taguchi, K., Matsumoto, T., & Kamata, K. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09133fp · Cited by 19
Al-Shamasi, A.-A., Elkaffash, R., Mohamed, M., Rayan, M., Al-Khater, D., Gadeau, A., Ahmed, R., Hasan, A., Eldassouki, H., Yalcin, H. C., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312677 · Cited by 19
“Reduced NO production is observed in diabetic experimental models [22,23], and in vitro studies with endothelial cells have shown that high glucose levels lead to less NO production [24].”
BackgroundWang, H., Zhou, Y., Guo, Z., Dong, Y. H., Xu, J., Huang, H., Liu, H., & Wang, W. (2017) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248417715001 · Cited by 19
“The main cause of death in diabetic patients is cardiovascular complications, and endothelial dysfunction is considered as an early event in the process of cardiovascular diseases.(2) However, until now, the underlying mechanisms involved in endothelial dysfunction in diabetes are not yet fully understood.”
BackgroundGaertner, S., Cordeanu, E., Mirea, C., Frantz, A., Auger, C., Bilbault, P., Ohlmann, P., Schini‐Kerth, V. B., & Stéphan, D. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.11.055 · Cited by 19
Kajikuri, J., Watanabe, Y., Ito, Y., Ito, R., Yamamoto, T., & Itoh, T. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00348.x · Cited by 19
“Indeed, in the regulation of coronary artery vasomotor function, NO and EDHF are thought to play central roles (Kugiyama et al., 1997; De Vriese et al., 2000).”
BackgroundInfluentialMayhan, W. G., Trauernicht, A. K., & Irvine, S. D. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03314-x · Cited by 19
Hyperglycaemia and its relation to cardiovascular morbidity and mortality: has it been resolved?
Yosefy, C. (2003) · Acta Diabetologica · doi:10.1007/s00592-003-0124-9 · Cited by 19
“Hyperglycaemia inhibits production of nitric oxide by blocking eNOS synthase activation and increasing the production of reactive oxygen species, especially superoxide anion (O-2), in endothelial and vascular smooth muscle cells [40].”
BackgroundMorán, A., Restrepo, B., de Urbina, A. V. O., García, M., Martín, M. L., & Román, L. S. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.06.013 · Cited by 19
Diabetes mellitus and experimental vein graft structure and function
Davies, M. G., Kim, J. H., Klyachkin, M. L., Barber, L., Dalen, H., Svendsen, E., Carson, C. C., & Hagen, P. (1994) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(94)70215-2 · Cited by 19
Plante, G. E., Perreault, M., Lanthier, A., Marette, A., & Maheux, P. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00521-2 · Cited by 19
Thomas, G. N., Tomlinson, B., Abdullah, A. S. M., Yeung, M. W., Chan, J. C. N., & Wong, K. S. (2005) · Diabetes Care · doi:10.2337/diacare.28.8.2051 · Cited by 19
“Even moderately high glucose levels affect the vasculature (17), and result in the accumulation of advanced glycation end products (18) that promote vascular disease and neuropathy, and thus contribute to ED (18).”
BackgroundSelective Up-Regulation of Arginase-1 in Coronary Arteries of Diabetic Patients
Bagi, Z. A., Fehér, A., Dou, H., & Brosková, Z. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00293 · Cited by 18
Bagi, Z. A., Fehér, A., & Beleznai, T. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70011-8 · Cited by 18
“arteries is established [14].”
Kiyooka, T., Ohanyan, V. A., Yin, L., Pung, Y. F., Chen, Y., Chen, C., Kang, P. T., Hardwick, J. P., Yun, J. S., Janota, D., et al. (2022) · Basic Research in Cardiology · doi:10.1007/s00395-021-00908-1 · Cited by 18
Hypoglycemia induces vascular endothelial dysfunction in subjects with normal glucose tolerance
Tanaka, K., Okada, Y., Torimoto, K., Nishio, K., Narisawa, M., & Tanaka, Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-06450-x · Cited by 18
Gokina, N. I., Bonev, A. D., Phillips, J. K., Gokin, A. P., Veilleux, K. M., Oppenheimer, K. H., & Goloman, G. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00901.2014 · Cited by 18
Role of glucagon-like peptide- 1 in vascular endothelial dysfunction.
Goyal, S., Kumar, S., Bijjem, K. R. V., & Singh, M. (2010) · PubMed · Cited by 18
Morales‐Cano, D., Moreno, L., Barreira, B., Briones, A. M., Pandolfi, R., Moral‐Sanz, J., Callejo, M., Mondéjar‐Parreño, G., Cortijo, J., Salaíces, M., et al. (2016) · Clinical Science · doi:10.1042/cs20160141 · Cited by 18
Uslu, G. A., Gelen, V., Uslu, H., & Özen, H. (2018) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902018000317785 · Cited by 18
“However, it has been suggested that endothelial damage may be due to decreased endothelium-derived relaxing factor (EDRF) production and hence diminished smooth muscle response to EDRF (De Vriese et al., 2000).”
BackgroundAngiotensin-(1–7) and bradykinin interaction in diabetes mellitus: in vivo study
Oliveira, M., de Carvalho, M. H. C., Nigro, D., Tostes, R. C., & Fortes, Z. B. (2002) · Peptides · doi:10.1016/s0196-9781(02)00080-3 · Cited by 18
Presley, T. D., Vedam, K., Druhan, L. J., & Ilangovan, G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.147728 · Cited by 18
Francischetti, E. A., Celoria, B. M. J., Francischetti, A., & Genelhu, V. A. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.3.289 · Cited by 18
Matsumoto, T., Ishida, K., Taguchi, K., Kobayashi, T., & Kamata, K. (2009) · Peptides · doi:10.1016/j.peptides.2009.12.017 · Cited by 18
Minocycline with Aspirin: An Approach to Attenuate Diabetic Nephropathy in Rats
Bhatt, L. K., & Addepalli, V. (2011) · Renal Failure · doi:10.3109/0886022x.2010.528117 · Cited by 18
Tardif, K., Hertig, V., Dumais, C., Villeneuve, L. R., Perrault, L. P., Tanguay, J., & Calderone, A. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0119-6 · Cited by 18
“An incipient pathophysiological event of diabetic vascular disease was an imbalance of homeostasis due to increased vasoconstriction secondary to impaired endothelial cell reactivity that occurred prior to the onset of overt clinical symptoms [1-3].”
BackgroundImpaired endothelium mediated vascular reactivity in endogenous Cushing's syndrome
Chandran, D. S., Jaryal, A. K., Jyotsna, V. P., & Deepak, K. K. (2011) · Endocrine Journal · doi:10.1507/endocrj.ej11-0030 · Cited by 18
Endothelial cell dysfunction in type I and II diabetes: The cellular basis for dysfunction
Pannirselvam, M., Anderson, T. J., & Triggle, C. R. (2003) · Drug Development Research · doi:10.1002/ddr.10127 · Cited by 18
Gender Differences in Vascular Reactivity of Aortas from Streptozotocin-Induced Diabetic Mice
Takenouchi, Y., Kobayashi, T., Taguchi, K., Matsumoto, T., & Kamata, K. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.1692 · Cited by 18
Granstam, E., & Granstam, S. (2003) · Physiological Research · doi:10.33549/physiolres.930281 · Cited by 18
“In diabetes, evidence for a reduced NO bioactivity has been found (De Vriese et al. 2000) either due to a decreased production of basal NO, a reduced availability of the substrate L-arginine for the NOproducing enzyme, the nitric oxide synthase (NOS) (Pieper and Peltier 1995) or an increased…”
Metadata
- Authors
- De Vriese, A. S., Verbeuren, T. J., Van de Voorde, J., Lameire, N. H., & Vanhoutte, P. M.
- Affiliations
- Institut Servier (FR)
- Ghent University (BE)
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2000-07
- Volume
- 130
- Issue
- 5
- Pages
- 963-974
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1572156
- OpenAlex
- W2007880055
- Cited by
- 1,165
- References
- 114
- Citations by year
- 2026: 9 · 2025: 23 · 2024: 32 · 2023: 15 · 2022: 31 · 2021: 27 · 2020: 44 · 2019: 39 · 2018: 41 · 2017: 31 · 2016: 36 · 2015: 50 · 2014: 56 · 2013: 58 · 2012: 62
- FWCI
- 5.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- endothelial dysfunction, diabetes mellitus, diabetic vascular disease, endothelium-derived relaxing factor, nitric oxide, prostacyclin, endothelium-derived hyperpolarizing factor, endothelium-dependent vasodilation, protein kinase C, polyol pathway, glycation, oxidative stress, hyperglycemia, ACE inhibitors, folic acid, vascular smooth muscle
- MeSH terms
- Animals, Biological Factors, Diabetes Mellitus, Endothelium, Vascular, Humans, Nitric Oxide, Protein Kinase C, Vasodilation, Signal Transduction, Endothelins, Glycation End Products, Advanced, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.